glutamic acid has been researched along with 1-octanol in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Padmashri, R; Sikdar, SK | 1 |
| Antunes Soares, FA; Aschner, M; Bicca Obetine Baptista, F; Duarte Hartmann, D; Farina Gonçalves, D; Franzen da Silva, A; Lenz Dalla Corte, C; Limana da Silveira, T; Lopes Machado, M; Marafiga Cordeiro, L | 1 |
2 other study(ies) available for glutamic acid and 1-octanol
| Article | Year |
|---|---|
Glutamate pretreatment affects Ca2+ signaling in processes of astrocyte pairs.
Topics: 1-Octanol; Analysis of Variance; Animals; Animals, Newborn; Astrocytes; Brain; Calcium; Calcium Signaling; Cells, Cultured; Electric Stimulation; Excitatory Amino Acid Antagonists; Gap Junctions; Glial Fibrillary Acidic Protein; Glutamic Acid; Glycine; Immunohistochemistry; Inositol 1,4,5-Trisphosphate; Intracellular Fluid; Membrane Potentials; Models, Biological; Patch-Clamp Techniques; Rats; Rats, Wistar | 2007 |
Caenorhabditis elegans as a model for studies on quinolinic acid-induced NMDAR-dependent glutamatergic disorders.
Topics: 1-Octanol; Adenosine Triphosphate; Amino Acid Metabolism, Inborn Errors; Animals; Animals, Genetically Modified; Caenorhabditis elegans; Citrate (si)-Synthase; Disease Models, Animal; Glutamic Acid; Humans; Kynurenine; Motor Activity; Neurodegenerative Diseases; Quinolinic Acid; Receptors, N-Methyl-D-Aspartate; Signal Transduction; Synaptic Transmission | 2021 |